Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder


Eli Lilly and Company News Releases

Get the latest updates from Eli Lilly and Company News Releases directly as they happen.

Follow now 216 followers

Latest posts

Last updated about 22 hours ago

Lilly Increases Manufacturing Investment to $9 Billion at Newest Indiana Site to Boost API Production for Tirzepatide and Pipeline Medicines

about 23 hours ago

Largest investment in active pharmaceutical ingredient manufacturing of synthetic medicines in U.S...

Lilly Announces Details of Presentations at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

1 day ago

INDIANAPOLIS , May 23, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE...

With Once-a-Week Dosing, Insulin Efsitora Alfa Delivers A1C Reduction and Safety Profile Consistent with Daily Insulin

9 days ago

Efsitora met the primary endpoint in both QWINT-2 and QWINT-4 with once-a-week...

Alonzo Weems to Retire as Executive Vice President of Enterprise Risk Management and Chief Ethics and Compliance Officer

10 days ago

INDIANAPOLIS , May 15, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE...

Lilly Update on Mounjaro® and Zepbound® (tirzepatide) Compounding Litigation

11 days ago

Following a series of lawsuits Eli Lilly and Company filed in September...

Lilly Statement on FDA Advisory Committee Meeting on Donanemab for Early Symptomatic Alzheimer’s Disease

18 days ago

The U.S. Food and Drug Administration (FDA) will convene an in-person meeting...

Lilly Declares Second-Quarter 2024 Dividend

19 days ago

INDIANAPOLIS , May 6, 2024   /PRNewswire/ -- The board of directors of...

Lilly Reports First-Quarter 2024 Financial Results and Raises Full-Year Revenue Guidance by $2 Billion, Highlights Pipeline Momentum

25 days ago

Revenue in Q1 2024 increased 26%, driven by Mounjaro, Zepbound, Verzenio and...

Lilly Recommends Shareholders Reject “Mini-Tender” Offer by Tutanota LLC

29 days ago

INDIANAPOLIS, April 26, 2024 – Eli Lilly and Company (NYSE: LLY) has...

Lilly Acquires New Injectable Medicine Manufacturing Facility from Nexus Pharmaceuticals

about 1 month ago

Upon completion, this acquisition will expand Lilly's growing U.S. capacity to produce...

Tirzepatide reduced sleep apnea severity by up to nearly two-thirds in adults with obstructive sleep apnea (OSA) and obesity

about 1 month ago

Tirzepatide achieved a mean apnea-hypopnea index reduction of up to 63% (about...